
VYNE Therapeutics VYNE
$ 0.67
1.84%
Quarterly report 2026-Q1
added 05-15-2026
VYNE Therapeutics EV/EBITDA Ratio 2011-2026 | VYNE
Annual EV/EBITDA Ratio VYNE Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.236 | -2.13 | -0.00723 | 0.403 | -0.407 | -2.05 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.403 | -2.13 | -0.738 |